LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Adult mice expressing a Braf Q241R mutation on an ICR/CD-1 background exhibit a cardio-facio-cutaneous syndrome phenotype.

    Moriya, Mitsuji / Inoue, Shin-Ichi / Miyagawa-Tomita, Sachiko / Nakashima, Yasumi / Oba, Daiju / Niihori, Tetsuya / Hashi, Misato / Ohnishi, Hiroshi / Kure, Shigeo / Matsubara, Yoichi / Aoki, Yoko

    Human molecular genetics

    2015  Volume 24, Issue 25, Page(s) 7349–7360

    Abstract: Activation of the RAS pathway has been implicated in oncogenesis and developmental disorders called RASopathies. Germline mutations in BRAF have been identified in 50-75% of patients with cardio-facio-cutaneous (CFC) syndrome, which is characterized by ... ...

    Abstract Activation of the RAS pathway has been implicated in oncogenesis and developmental disorders called RASopathies. Germline mutations in BRAF have been identified in 50-75% of patients with cardio-facio-cutaneous (CFC) syndrome, which is characterized by congenital heart defects, distinctive facial features, short stature and ectodermal abnormalities. We recently demonstrated that mice expressing a Braf Q241R mutation, which corresponds to the most frequent BRAF mutation (Q257R) in CFC syndrome, on a C57BL/6J background are embryonic/neonatal lethal, with multiple congenital defects, preventing us from analyzing the phenotypic consequences after birth. Here, to further explore the pathogenesis of CFC syndrome, we backcrossed these mice onto a BALB/c or ICR/CD-1 genetic background. On a mixed (BALB/c and C57BL/6J) background, all heterozygous Braf(Q241R/+) mice died between birth and 24 weeks and exhibited growth retardation, sparse and ruffled fur, liver necrosis and atrial septal defects (ASDs). In contrast, 31% of the heterozygous Braf(Q241R/+) ICR mice survived over 74 weeks. The surviving Braf(Q241R/+) ICR mice exhibited growth retardation, sparse and ruffled fur, a hunched appearance, craniofacial dysmorphism, long and/or dystrophic nails, extra digits and ovarian cysts. The Braf(Q241R/+) ICR mice also showed learning deficits in the contextual fear-conditioning test. Echocardiography indicated the presence of pulmonary stenosis and ASDs in the Braf(Q241R/+) ICR mice, which were confirmed by histological analysis. These data suggest that the heterozygous Braf(Q241R/+) ICR mice show similar phenotypes as CFC syndrome after birth and will be useful for elucidating the pathogenesis and potential therapeutic strategies for RASopathies.
    MeSH term(s) Animals ; Blotting, Western ; Echocardiography ; Ectodermal Dysplasia/genetics ; Facies ; Failure to Thrive/genetics ; Female ; Genotype ; Heart Defects, Congenital/genetics ; Male ; Mice ; Mice, Inbred BALB C ; Microscopy, Electron ; Mutation/genetics ; Proto-Oncogene Proteins B-raf/genetics
    Chemical Substances Braf protein, mouse (EC 2.7.11.1) ; Proto-Oncogene Proteins B-raf (EC 2.7.11.1)
    Language English
    Publishing date 2015-12-20
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1108742-0
    ISSN 1460-2083 ; 0964-6906
    ISSN (online) 1460-2083
    ISSN 0964-6906
    DOI 10.1093/hmg/ddv435
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: New BRAF knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardio-facio-cutaneous syndrome.

    Inoue, Shin-Ichi / Moriya, Mitsuji / Watanabe, Yusuke / Miyagawa-Tomita, Sachiko / Niihori, Tetsuya / Oba, Daiju / Ono, Masao / Kure, Shigeo / Ogura, Toshihiko / Matsubara, Yoichi / Aoki, Yoko

    Human molecular genetics

    2014  Volume 23, Issue 24, Page(s) 6553–6566

    Abstract: Cardio-facio-cutaneous (CFC) syndrome is one of the 'RASopathies', a group of phenotypically overlapping syndromes caused by germline mutations that encode components of the RAS-MAPK pathway. Germline mutations in BRAF cause CFC syndrome, which is ... ...

    Abstract Cardio-facio-cutaneous (CFC) syndrome is one of the 'RASopathies', a group of phenotypically overlapping syndromes caused by germline mutations that encode components of the RAS-MAPK pathway. Germline mutations in BRAF cause CFC syndrome, which is characterized by heart defects, distinctive facial features and ectodermal abnormalities. To define the pathogenesis and to develop a potential therapeutic approach in CFC syndrome, we here generated new knockin mice (here Braf(Q241R/+)) expressing the Braf Q241R mutation, which corresponds to the most frequent mutation in CFC syndrome, Q257R. Braf(Q241R/+) mice manifested embryonic/neonatal lethality, showing liver necrosis, edema and craniofacial abnormalities. Histological analysis revealed multiple heart defects, including cardiomegaly, enlarged cardiac valves, ventricular noncompaction and ventricular septal defects. Braf(Q241R/+) embryos also showed massively distended jugular lymphatic sacs and subcutaneous lymphatic vessels, demonstrating lymphatic defects in RASopathy knockin mice for the first time. Prenatal treatment with a MEK inhibitor, PD0325901, rescued the embryonic lethality with amelioration of craniofacial abnormalities and edema in Braf(Q241R/+) embryos. Unexpectedly, one surviving pup was obtained after treatment with a histone 3 demethylase inhibitor, GSK-J4, or NCDM-32b. Combination treatment with PD0325901 and GSK-J4 further increased the rescue from embryonic lethality, ameliorating enlarged cardiac valves. These results suggest that our new Braf knockin mice recapitulate major features of RASopathies and that epigenetic modulation as well as the inhibition of the ERK pathway will be a potential therapeutic strategy for the treatment of CFC syndrome.
    MeSH term(s) Animals ; Benzamides/pharmacology ; Benzazepines/pharmacology ; Diphenylamine/analogs & derivatives ; Diphenylamine/pharmacology ; Disease Models, Animal ; Drug Synergism ; Ectodermal Dysplasia/drug therapy ; Ectodermal Dysplasia/genetics ; Ectodermal Dysplasia/metabolism ; Ectodermal Dysplasia/pathology ; Embryo, Mammalian ; Facies ; Failure to Thrive/drug therapy ; Failure to Thrive/genetics ; Failure to Thrive/metabolism ; Failure to Thrive/pathology ; Female ; Gene Expression Regulation ; Gene Knock-In Techniques ; Genes, Lethal ; Heart Defects, Congenital/drug therapy ; Heart Defects, Congenital/genetics ; Heart Defects, Congenital/metabolism ; Heart Defects, Congenital/pathology ; Histone Deacetylase Inhibitors/pharmacology ; Histone Demethylases/antagonists & inhibitors ; Histone Demethylases/genetics ; Histone Demethylases/metabolism ; Humans ; Liver/abnormalities ; Liver/drug effects ; MAP Kinase Kinase Kinases/antagonists & inhibitors ; MAP Kinase Kinase Kinases/genetics ; MAP Kinase Kinase Kinases/metabolism ; Male ; Mice ; Mice, Transgenic ; Mutation ; Myocardium/pathology ; Protein Kinase Inhibitors/pharmacology ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins B-raf/metabolism ; Pyrimidines/pharmacology ; Signal Transduction ; Skull/abnormalities ; Skull/drug effects
    Chemical Substances Benzamides ; Benzazepines ; GSK-J4 ; Histone Deacetylase Inhibitors ; Protein Kinase Inhibitors ; Pyrimidines ; mirdametinib (86K0J5AK6M) ; Diphenylamine (9N3CBB0BIQ) ; Histone Demethylases (EC 1.14.11.-) ; Braf protein, mouse (EC 2.7.11.1) ; Proto-Oncogene Proteins B-raf (EC 2.7.11.1) ; MAP Kinase Kinase Kinases (EC 2.7.11.25)
    Language English
    Publishing date 2014-07-17
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1108742-0
    ISSN 1460-2083 ; 0964-6906
    ISSN (online) 1460-2083
    ISSN 0964-6906
    DOI 10.1093/hmg/ddu376
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top